Attached files
file | filename |
---|---|
8-K - 8-K - LANNETT CO INC | a15-20664_18k.htm |
EX-99.1 - EX-99.1 - LANNETT CO INC | a15-20664_1ex99d1.htm |
EX-99.4 - EX-99.4 - LANNETT CO INC | a15-20664_1ex99d4.htm |
EX-99.2 - EX-99.2 - LANNETT CO INC | a15-20664_1ex99d2.htm |
Exhibit 99.3
Unaudited Pro Forma Combined Financial Statements of Lannett Company, Inc.
Lannett Company, Inc. (Lannett or LCI) expects to complete the acquisition of Kremers Urban Pharmaceuticals Inc. (KUPI) for approximately $1.25 billion in aggregate consideration (the Acquisition). Lannett anticipates funding the Acquisition with proceeds from the issuance of the $1.16 billion senior secured term loan facility and cash on hand. Lannett obtained commitments for senior secured credit facilities in an aggregate principal amount of up to $1.285 billion comprised of (i) a senior secured term loan facility in an aggregate principal amount of up to $1.16 billion (the Term Loan Facility) and (ii) a senior secured revolving credit facility in an aggregate principal amount of up to $125.0 million (the Revolving Credit Facility and, together with the Term Loan Facility, the Senior Secured Credit Facility and, together with the Acquisition, the Transactions). Under the terms of the commitment letter relating to the Senior Secured Credit Facility, the Term Loan Facility will be reduced in an amount equal to the proceeds of any debt or equity securities that Lannett issues prior to closing the Acquisition for the purpose of funding the Acquisition.
As used herein, the terms the Company, we, and our refer to Lannett Company, Inc., and where applicable, its consolidated subsidiaries. The Company and KUPI have different fiscal year ends. The financial periods presented in this Form 8-K are based on our fiscal periods. For the purpose of presenting these pro forma financial statements, we used the financial statements for our fiscal year ended June 30, 2015, as filed with the Securities and Exchange Commission (SEC) in our most recent Annual Report on Form 10-K. To meet the SECs pro forma requirements of combining operating results for KUPI for an annual period that ends within 93 days of the end of our latest annual fiscal period as filed with the SEC, we adjusted KUPIs historical financial information for the year ended December 31, 2014 to include the interim period ended June 30, 2015 and subtracted the comparable interim period ended June 30, 2014. We combined this KUPI unaudited historical financial information for the twelve months ended June 30, 2015 with our fiscal year ended June 30, 2015 financial information to prepare the pro forma financial statements. The Unaudited Pro Forma Combined Balance Sheet as of June 30, 2015 gives effect to the KUPI acquisition as if it had occurred on that date and includes historical data as reported by the separate companies. The Unaudited Pro Forma Combined Statement of Operations for the twelve months ended June 30, 2015 gives effect to the KUPI acquisition as if it had been consummated on July 1, 2014 and includes historical data as reported by the separate companies. The historical financial information has been adjusted to give effect to events that are (i) directly attributable to the acquisition, (ii) factually supportable, and (iii) with respect to the statement of operations, expected to have a continuing impact on the combined results of the companies. The detailed assumptions used to prepare the pro forma financial information are contained in the notes to the Unaudited Pro Forma Combined Financial Statements (Pro Forma Statements).
The acquisition has been accounted for as a business combination (in accordance with ASC 805 Business Combinations) and, as such, KUPIs assets acquired and liabilities assumed have been recorded at their respective fair values. The determination of fair value for the identifiable tangible and intangible assets acquired and liabilities assumed requires extensive use of accounting estimates and judgments. Significant estimates and assumptions include, but are not limited to: determining the timing and estimated costs to complete the in-process research and development projects, projecting the likelihood and timing of obtaining regulatory approval, estimating future cash flows and determining the appropriate discount rate. The estimated fair values of the assets acquired and liabilities assumed on the KUPI acquisition date included in the Pro Forma Statements are provisional and subject to change. Any changes to the final fair values could be material.
The pro forma adjustments reflecting the consummation of the KUPI acquisition are based upon the acquisition method of accounting in accordance with U.S. generally accepted accounting principles and upon the assumptions set forth in the Notes included in this section. The Pro Forma Statements have been prepared based on available information, using estimates and assumptions that our management believes are reasonable. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Pro Forma Statements and the reported amounts of revenues and expenses during the reporting period. These estimates and assumptions are preliminary and have been made solely for purposes of developing these Pro Forma Statements. The Unaudited Pro Forma Combined Balance Sheet has been adjusted to reflect the allocation of the purchase price to identifiable net assets acquired and of the excess purchase price to goodwill.
The Unaudited Pro Forma Combined Statement of Operations does not purport to represent the actual results of operations that would have occurred if the acquisition had taken place on the date specified and are not necessarily indicative of the results of operations that may be achieved in the future. The Unaudited Pro Forma Combined Statement of Operations does not reflect any adjustments for the effect of non-recurring items or operating synergies that we may realize as a result of the acquisition. The Pro Forma Statements include certain reclassifications to conform the historical financial information of KUPI to our presentation (see Note 4 in the accompanying notes).
The assumptions used and adjustments made in preparing the Pro Forma Statements are described in the Notes, which should be read in conjunction with the Pro Forma Statements. The Pro Forma Statements and related Notes contained herein should be read in conjunction with the Consolidated Financial Statements and related Notes included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2015.
LANNETT COMPANY, INC.
UNAUDITED PRO FORMA COMBINED BALANCE SHEET
AS OF JUNE 30, 2015
(In thousands)
|
|
Lannett Company, Inc. |
|
Kremers Urban |
|
Pro Forma |
|
|
|
Lannett Company, Inc. |
| ||||
|
|
Historical (1) |
|
Reclassified Historical (2) |
|
Adjustments (3) |
|
|
|
Pro Forma Combined |
| ||||
ASSETS |
|
|
|
|
|
|
|
|
|
|
| ||||
Current Assets: |
|
|
|
|
|
|
|
|
|
|
| ||||
Cash and cash equivalents |
|
$ |
200,340 |
|
$ |
1,183 |
|
$ |
(114,274 |
) |
(a) |
|
$ |
87,249 |
|
Investment securities |
|
13,467 |
|
|
|
|
|
|
|
13,467 |
| ||||
Accounts receivable, net |
|
91,103 |
|
199,834 |
|
|
|
|
|
290,937 |
| ||||
Inventories, net |
|
46,191 |
|
61,598 |
|
26,526 |
|
(b) |
|
134,315 |
| ||||
Prepaid income taxes |
|
|
|
|
|
2,370 |
|
(c) |
|
2,370 |
| ||||
Deferred tax assets |
|
16,270 |
|
38,969 |
|
(35,073 |
) |
(d) |
|
20,166 |
| ||||
Other current assets |
|
3,175 |
|
1,390 |
|
|
|
|
|
4,565 |
| ||||
Total current assets |
|
370,546 |
|
302,974 |
|
(120,451 |
) |
|
|
553,069 |
| ||||
Property, plant, and equipment, net |
|
94,556 |
|
94,113 |
|
|
|
|
|
188,669 |
| ||||
Intangible assets, net |
|
29,090 |
|
5,892 |
|
618,278 |
|
(e) |
|
653,260 |
| ||||
Goodwill |
|
141 |
|
177,957 |
|
107,017 |
|
(f) |
|
285,115 |
| ||||
Deferred tax assets |
|
12,495 |
|
|
|
1,095 |
|
(d) |
|
13,590 |
| ||||
Other assets |
|
1,938 |
|
|
|
67,295 |
|
(g) |
|
69,233 |
| ||||
TOTAL ASSETS |
|
$ |
508,766 |
|
$ |
580,936 |
|
$ |
673,234 |
|
|
|
$ |
1,762,936 |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
LIABILITIES |
|
|
|
|
|
|
|
|
|
|
| ||||
Current liabilities: |
|
|
|
|
|
|
|
|
|
|
| ||||
Accounts payable |
|
$ |
19,195 |
|
$ |
16,280 |
|
$ |
|
|
|
|
$ |
35,475 |
|
Accrued expenses |
|
4,928 |
|
4,826 |
|
|
|
|
|
9,754 |
| ||||
Accrued payroll and payroll-related expenses |
|
10,397 |
|
10,116 |
|
4,177 |
|
(h) |
|
24,690 |
| ||||
Rebates payable |
|
7,553 |
|
8,995 |
|
|
|
|
|
16,548 |
| ||||
Royalties payable |
|
|
|
9,128 |
|
|
|
|
|
9,128 |
| ||||
Income taxes payable |
|
1,340 |
|
|
|
(1,340 |
) |
(c) |
|
|
| ||||
Current portion of long-term debt |
|
135 |
|
|
|
11,600 |
|
(k) |
|
11,735 |
| ||||
Total current liabilities |
|
43,548 |
|
49,345 |
|
14,437 |
|
|
|
107,330 |
| ||||
Long-term debt, less current portion |
|
874 |
|
|
|
1,148,400 |
|
(k) |
|
1,149,274 |
| ||||
Acquisition-related contingent consideration |
|
|
|
|
|
35,000 |
|
(l) |
|
35,000 |
| ||||
Deferred tax liabilities |
|
|
|
60 |
|
(60 |
) |
(j) |
|
|
| ||||
Liabilities for uncertain tax positions |
|
578 |
|
34,779 |
|
(14,404 |
) |
(i) |
|
20,953 |
| ||||
Other long-term liabilities |
|
|
|
1,524 |
|
510 |
|
(m) |
|
2,034 |
| ||||
TOTAL LIABILITIES |
|
45,000 |
|
85,708 |
|
1,183,883 |
|
|
|
1,314,591 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
| ||||
STOCKHOLDERS EQUITY |
|
|
|
|
|
|
|
|
|
|
| ||||
Common Stock |
|
37 |
|
|
|
|
|
|
|
37 |
| ||||
Additional paid-in capital |
|
236,178 |
|
234,668 |
|
(234,668 |
) |
(n) |
|
236,178 |
| ||||
Retained earnings |
|
233,573 |
|
258,913 |
|
(274,334 |
) |
(n) |
|
218,152 |
| ||||
Accumulated other comprehensive loss |
|
(295 |
) |
1,647 |
|
(1,647 |
) |
(n) |
|
(295 |
) | ||||
Treasury stock |
|
(6,080 |
) |
|
|
|
|
|
|
(6,080 |
) | ||||
Total Lannett Company, Inc. stockholders equity |
|
463,413 |
|
495,228 |
|
(510,649 |
) |
|
|
447,992 |
| ||||
Noncontrolling interests |
|
353 |
|
|
|
|
|
|
|
353 |
| ||||
Total stockholders equity |
|
463,766 |
|
495,228 |
|
(510,649 |
) |
|
|
448,345 |
| ||||
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY |
|
$ |
508,766 |
|
$ |
580,936 |
|
$ |
673,234 |
|
|
|
$ |
1,762,936 |
|
(1) Represents audited results for the year ended June 30, 2015 as reported on Form 10-K filed with the SEC on August 27, 2015. Liabilities for uncertain tax positions have been reclassified from Income taxes payable into a separate financial statement line item for purposes of these pro forma financial statements. This reclassification is not significant and does not materially change the historical audited financial statements as reported on our Form 10-K.
(2) Certain amounts have been reclassified to conform to Lannetts presentation. Refer to Note 4. Reclassifications below. The accompanying Notes are an integral part of the Unaudited Pro Forma Combined Financial Statements. Kremers Urban Pharmaceuticals Inc. financial data is for the last twelve months ended June 30, 2015.
(3) See Note 3. Pro Forma Adjustments below.
LANNETT COMPANY, INC.
UNAUDITED PRO FORMA COMBINED STATEMENT OF OPERATIONS
FOR THE TWELVE MONTHS ENDED JUNE 30, 2015
(In thousands)
|
|
Lannett Company, Inc. |
|
Kremers Urban |
|
Pro Forma |
|
|
|
Lannett Company, Inc. |
| ||||
|
|
Historical (1) |
|
Reclassified Historical (2) |
|
(3) |
|
|
|
Pro Forma Combined |
| ||||
Net sales |
|
$ |
406,837 |
|
$ |
406,567 |
|
$ |
|
|
|
|
$ |
813,404 |
|
Cost of sales |
|
100,481 |
|
238,736 |
|
30,551 |
|
(o) |
|
369,768 |
| ||||
Gross profit |
|
306,356 |
|
167,831 |
|
(30,551 |
) |
|
|
443,636 |
| ||||
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
| ||||
Research and development |
|
30,342 |
|
30,292 |
|
(2,895 |
) |
(p) |
|
57,739 |
| ||||
Selling, general and administrative |
|
49,527 |
|
26,512 |
|
(8,360 |
) |
(q) |
|
67,679 |
| ||||
Total operating expenses |
|
79,869 |
|
56,804 |
|
(11,255 |
) |
|
|
125,418 |
| ||||
Operating income |
|
226,487 |
|
111,027 |
|
(19,296 |
) |
|
|
318,218 |
| ||||
Other income (loss): |
|
|
|
|
|
|
|
|
|
|
| ||||
Foreign currency loss |
|
(21 |
) |
(518 |
) |
|
|
|
|
(539 |
) | ||||
Gain on sale of assets |
|
33 |
|
50 |
|
|
|
|
|
83 |
| ||||
Gain on investment securities |
|
705 |
|
|
|
|
|
|
|
705 |
| ||||
Interest and dividend income |
|
425 |
|
|
|
|
|
|
|
425 |
| ||||
Interest expense |
|
(207 |
) |
|
|
(67,623 |
) |
(r) |
|
(67,830 |
) | ||||
Total other income (loss) |
|
935 |
|
(468 |
) |
(67,623 |
) |
|
|
(67,156 |
) | ||||
Income before income taxes |
|
227,422 |
|
110,559 |
|
(86,919 |
) |
|
|
251,062 |
| ||||
Income tax expense |
|
77,430 |
|
25,206 |
|
(31,352 |
) |
(s) |
|
71,284 |
| ||||
Net income |
|
149,992 |
|
85,353 |
|
(55,567 |
) |
|
|
179,778 |
| ||||
Less: Net income attributable to noncontrolling interest |
|
73 |
|
|
|
|
|
|
|
73 |
| ||||
Net income attributable to Lannett Company, Inc. |
|
$ |
149,919 |
|
$ |
85,353 |
|
$ |
(55,567 |
) |
|
|
$ |
179,705 |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Earnings per common share attributable to Lannett Company, Inc.: |
|
|
|
|
|
|
|
|
|
|
| ||||
Basic |
|
$ |
4.18 |
|
|
|
|
|
(t) |
|
$ |
5.02 |
| ||
Diluted |
|
$ |
4.04 |
|
|
|
|
|
(t) |
|
$ |
4.84 |
| ||
|
|
|
|
|
|
|
|
|
|
|
| ||||
Weighted average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
| ||||
Basic |
|
35,827,167 |
|
|
|
|
|
|
|
35,827,167 |
| ||||
Diluted |
|
37,127,117 |
|
|
|
|
|
|
|
37,127,117 |
|
(1) Represents audited results for the year ended June 30, 2015 as reported on Form 10-K filed with the SEC on August 27, 2015.
(2) Certain amounts have been reclassified to conform to Lannetts presentation. Refer to Note 4. Reclassifications below. The accompanying Notes are an integral part of the Unaudited Pro Forma Combined Financial Statements. Kremers Urban Pharmaceuticals Inc. financial data is for the last twelve months ended June 30, 2015.
(3) See Note 3. Pro Forma Adjustments below.
LANNETT COMPANY, INC.
NOTES TO UNAUDITED PRO FORMA COMBINED
FINANCIAL STATEMENTS
Note 1. Basis of presentation
The Unaudited Pro Forma Combined Balance Sheet combines Lannett and KUPIs historical Consolidated Balance Sheets as of June 30, 2015.
The Unaudited Pro Forma Combined Statement of Operations for the twelve months ended June 30, 2015 combines the historical year ended June 30, 2015 results for Lannett and the twelve months ended June 30, 2015 for KUPI to conform to Lannetts fiscal year end.
The Unaudited Pro Forma Combined Statement of Operations does not reflect the non-recurring expenses that we expect to incur in connection with the Acquisition, including fees to financing sources, attorneys, accountants and other professional advisors, the write-off of deferred financing costs, and other transaction-related costs that will not be capitalized. Additionally, the Unaudited Pro Forma Combined Statement of Operations does not reflect the effects of any anticipated cost savings and any related non-recurring costs to achieve those cost savings. The Unaudited Pro Forma Combined Statement of Operations does not purport to represent our actual results of operations that would have occurred if the acquisitions had taken place on the dates specified, nor are they necessarily indicative of the results of operations that may be achieved in the future. The Unaudited Pro Forma Combined Statement of Operations includes certain reclassifications to conform the historical financial information of KUPI to our financial presentation.
Note 2. Acquisition of Kremers Urban Pharmaceuticals Inc.
Lannett anticipates completing the acquisition of 100% of the outstanding shares of KUPI, upon which KUPI will become a wholly-owned subsidiary of Lannett. KUPI was a privately-held subsidiary of UCB S.A., a specialty generic pharmaceutical company headquartered in Princeton, NJ, focused on difficult-to-formulate products as well as products using different specialized delivery technologies.
The following table summarizes the fair value of total consideration transferred to KUPI shareholders assuming an acquisition date of June 30, 2015:
(In thousands) |
|
|
| |
Cash consideration paid to KUPI shareholders (1) |
|
$ |
1,230,000 |
|
Working capital adjustment (2) |
|
(15,340 |
) | |
Total cash consideration transferred to KUPI shareholders |
|
1,214,660 |
| |
Contingent payment (3) |
|
35,000 |
| |
Total consideration transferred to KUPI shareholders |
|
$ |
1,249,660 |
|
(1) Cash consideration paid to KUPI shareholders will be provided by borrowings under Lannetts Term Loan Facility and cash on hand.
(2) Represents the working capital adjustment pursuant to the terms and conditions of the Stock Purchase Agreement dated September 2, 2015.
(3) Fair value contingent payment of $35 million represents the contingent payment related to the section 338(h)(10) election made pursuant to the Acquisition. Lannett has agreed to a 50/50 split of the additional tax liabilities UCB will incur associated with the section 338(h)(10) election, up to $35 million. We have accounted for this arrangement as contingent consideration and have recorded a liability of $35 million.
Assuming an acquisition date of June 30, 2015, the preliminary purchase price of KUPI would have been allocated to the following assets acquired and liabilities assumed:
(In thousands) |
|
June 30, 2015 |
| |
Accounts receivable, net of revenue-related reserves |
|
$ |
199,834 |
|
Inventories |
|
88,124 |
| |
Deferred tax assets |
|
3,896 |
| |
Other current assets |
|
1,390 |
| |
Property, plant and equipment |
|
94,113 |
| |
Other intangible assets |
|
21,170 |
| |
KUPI product rights |
|
453,000 |
| |
In-process research and development |
|
150,000 |
| |
Goodwill |
|
284,974 |
| |
Deferred tax assets |
|
1,095 |
| |
Other assets |
|
27,995 |
| |
Total assets acquired |
|
1,325,591 |
| |
Accounts payable |
|
(16,280 |
) | |
Accrued expenses |
|
(4,826 |
) | |
Accrued payroll and payroll-related expenses |
|
(14,293 |
) | |
Rebates payable |
|
(8,995 |
) | |
Royalties payable |
|
(9,128 |
) | |
Liabilities for uncertain tax positions |
|
(20,375 |
) | |
Other noncurrent liabilities |
|
(2,034 |
) | |
Total net assets acquired |
|
$ |
1,249,660 |
|
Note 3. Pro forma adjustments
(a) The pro forma adjustment to the Cash and cash equivalents balance represents the effects of the following transactions:
(In thousands) |
|
|
| |
Total estimated cash purchase price |
|
$ |
(1,230,000 |
) |
Working capital adjustment (1) |
|
15,340 |
| |
Debt proceeds (2) |
|
1,120,700 |
| |
Estimated direct transaction costs incurred by LCI in connection with the Acquisition |
|
(19,131 |
) | |
Elimination of KUPIs cash (3) |
|
(1,183 |
) | |
Net pro forma adjustment |
|
$ |
(114,274 |
) |
(1) Represents the working capital adjustment pursuant to the terms and conditions of the Stock Purchase Agreement dated September 2, 2015.
(2) Represents $1.16 billion proceeds (see (k)) received in connection with the issuance of the Term Loan Facility to fund a portion of the Acquisition, net of deferred financing fees of $39.3 million (see (g)).
(3) Represents the elimination of KUPIs cash balance pursuant to the terms and conditions of the Stock Purchase Agreement dated September 2, 2015.
(b) Adjustment is to record the fair value step up for acquired inventory. Finished goods and work-in-process inventory have been recorded at estimated selling price less the sum of costs of disposal, a reasonable profit allowance for our selling effort, and estimated costs to complete for work-in-process inventory. Raw material inventory has been valued at current replacement cost, which approximated KUPIs carrying value. As there is no continuing impact of the inventory step-up on the Companys results, the cost of sales associated with the increased inventory value is not included in the Unaudited Pro Forma Combined Statements of Operations.
(c) Included in the total $19.1 million direct transaction costs (see (a)) associated with acquiring KUPI, $10.3 million are estimated to be tax deductible. The adjustment reflects the tax effect of the tax deductible portion. A portion of this adjustment is netted against our historical income taxes payable balance totaling $1.34 million.
(d) Represents the net decrease in deferred tax assets consisting of (i) a $39.0 million adjustment to remove KUPIs historical current deferred tax asset, (ii) a $4.0 million adjustment to record the fair value of our current deferred tax assets, and (iii) a $1.1 million adjustment to record the fair value of our non-current deferred tax assets.
(e) The fair value of the intangible assets acquired and related amortization periods, as well as the reversal of KUPIs historical intangible assets, are reflected in the following pro forma adjustment:
(In thousands) |
|
|
|
Amortization |
| |
In-process research and development |
|
$ |
150,000 |
|
|
|
KUPI product rights |
|
453,000 |
|
15 |
| |
KUPI tradename |
|
2,170 |
|
2 |
| |
Contract manufacturing |
|
19,000 |
|
15 |
| |
Elimination of KUPIs historical intangible asset value |
|
(5,892 |
) |
|
| |
Net pro forma adjustment |
|
$ |
618,278 |
|
|
|
Pro forma adjustments related to amortization of definite-lived intangible assets are reflected on the Unaudited Pro Forma Combined Statement of Operations. See (o), (p), and (q).
The fair value of the KUPI product rights, in-process research and development and contract manufacturing assets were estimated using a discounted present value income approach. Under this method, an intangible assets fair value is equal to the present value of the incremental after-tax cash flows (excess earnings) attributable solely to the intangible asset over its remaining useful life. To calculate fair value, the Company used cash flows discounted at rates considered appropriate given the inherent risks associated with each type of asset. The Company believes that the level and timing of cash flows appropriately reflect market participant assumptions. The fair value of the KUPI tradename was estimated using an income approach, specifically known as the relief from royalty method. The relief from royalty method is based on a hypothetical royalty stream that would be received if the Company were to license the KUPI tradename. Thus, we derived the hypothetical royalty income from the projected revenues of KUPI products, respectively. Cash flows were assumed to extend through the remaining economic useful life of each class of intangible asset. These estimates and assumptions are preliminary and have been made solely for purposes of developing these Pro Forma Statements. Any changes to final estimates or amounts could be significant.
(f) Represents the net adjustment to goodwill consisting of (i) the reversal of KUPIs historical goodwill totaling $178.0 million and (ii) to record goodwill totaling $285.0 million for the excess of the purchase price over the fair value of the tangible and intangible assets acquired and liabilities assumed.
(g) The adjustment consists of the following components:
(In thousands) |
|
|
| |
Deferred financing fees (1) |
|
39,300 |
| |
Indemnification asset related to uncertain tax positions (see (i)) |
|
20,375 |
| |
Indemnification asset related to change-in-control payments (see (h)) |
|
7,620 |
| |
Net pro forma adjustment |
|
$ |
67,295 |
|
(1) The deferred financing fees will be amortized over the life of the Revolving Credit Facility and the Term Loan Facility which mature in 2020 and 2022, respectively. The amortization of deferred financing fees is reflected as a pro forma adjustment to the Unaudited Pro Forma Combined Statement of Operations (see (r)).
(h) Represents the net adjustment for change-in-control payments for certain employees in connection with the Acquisition. Adjustment reflects the elimination of KUPIs historical $3.4 million liability and the recording of $7.6 million (see (g)) to reflect the fair value of the liability assumed.
(i) The net pro forma adjustment includes (i) the elimination of $34.8 million historical KUPIs liabilities for uncertain tax positions and (ii) the recording of the fair value of the liability assumed related to uncertain tax positions totaling $20.4 million (see (g)).
(j) Represents the adjustment to eliminate KUPIs historical deferred tax liabilities.
(k) Represents the issuance of the Term Loan Facility to fund a portion of the Acquisition. The adjustment consists of the following components:
(In thousands) |
|
|
| |
Long-term debt, less current portion |
|
$ |
1,148,400 |
|
Current portion of long-term debt |
|
11,600 |
| |
Total Term Loan Facility |
|
$ |
1,160,000 |
|
(l) Represents the contingent payment related to the section 338(h)(10) election made pursuant to the Acquisition. Lannett has agreed to a 50/50 split of the additional tax liabilities UCB will incur associated with the section 338(h)(10) election, up to $35 million.
(m) Represents the recording of the estimated fair value for the KUPI environmental liability assumed.
(n) Represents the following adjustments to equity:
(In thousands) |
|
|
| |
Elimination of KUPIs historical additional paid-in capital |
|
$ |
(234,668 |
) |
Elimination of KUPIs historical retained earnings |
|
(258,913 |
) | |
Record estimated transaction costs incurred by LCI in connection with the Acquisition, net of $3.7 million tax effect (see (a) and (c)) |
|
(15,421 |
) | |
Elimination of KUPIs historical accumulated other comprehensive income |
|
(1,647 |
) | |
Net pro forma adjustment |
|
$ |
(510,649 |
) |
(o) Adjustment represents the net increase to cost of sales which consists of the following:
(In thousands) |
|
|
| |
Elimination of KUPIs historical amortization expense |
|
$ |
(916 |
) |
Record amortization expense for acquired definite-lived intangible assets (1) |
|
31,467 |
| |
Net pro forma adjustment |
|
$ |
30,551 |
|
(1) Amortization expense relates to the value of definite-lived intangible assets, recorded over the estimated useful lives of 15 years for currently marketed products and contract manufacturing (see (e)).
(p) Adjustment represents the elimination of KUPIs historical amortization expense classified as Research and development expense.
(q) Adjustment to Selling, general and administrative expense consists of the following:
(In thousands) |
|
|
| |
Elimination of KUPIs historical amortization expense |
|
$ |
(467 |
) |
Record amortization expense for the acquired KUPI tradename (1) |
|
1,085 |
| |
Elimination of KUPIs transaction costs (2) |
|
(5,732 |
) | |
Elimination of KUPIs change-in-control payments (3) |
|
(3,246 |
) | |
Net pro forma adjustment |
|
$ |
(8,360 |
) |
(1) Amortization expense relates to the value of the KUPI tradename and is recorded over the estimated useful life of 2 years (see (e)).
(2) Represents the transaction costs associated with the Acquisition recorded by KUPI for the twelve months ended June 30, 2015. The costs are non-recurring in nature and therefore eliminated for purposes of preparing the Unaudited Pro Forma Combined Statement of Operations.
(3) Represents the change-in-control payments recorded by KUPI for the twelve months ended June 30, 2015. The payments are non-recurring in nature and therefore eliminated for purposes of preparing the Unaudited Pro Forma Combined Statement of Operations.
(r) Adjustment represents the increase in interest expense, including amortization of deferred financing fees totaling $6.0 million, related to the issuance of the Senior Secured Credit Facility entered into in connection with the Acquisition. The variable interest rate on the Term Loan Facility was assumed based on the terms of commitment to provide the Senior Secured Credit Facility. If the Term Loan Facility was outstanding at June 30, 2015, each 1/8% increase in interest rates would yield $1.5 million of incremental annual interest expense.
(s) For purposes of this Unaudited Pro Forma Combined Statement of Operations, an estimated income tax rate of approximately 36% has been used for the pro forma adjustments for the twelve months ended June 30, 2015. The estimated income tax rate is based on the applicable enacted statutory tax rates for the period. These rates are estimates and do not take into account future income tax strategies that may be applied to the combined entity.
(t) The unaudited pro forma combined basic and diluted earnings per share for the period presented are based on the basic and diluted weighted-average number of common shares outstanding. The pro forma combined shares outstanding for the twelve months ended June 30, 2015 are not impacted by the Transactions, and are therefore consistent with Lannetts basic and diluted shares outstanding for the year ended June 30, 2015.
Note 4. Reclassifications
During the preparation of the Pro Forma Statements, we performed a review of KUPIs accounting policies in an effort to determine if differences in accounting policies require adjustment or reclassification of KUPIs results of operations or reclassification of assets or liabilities to conform to our accounting policies and classifications. We were not aware of any material differences between accounting policies of the two companies, except for certain reclassifications necessary to conform to our financial presentation, and accordingly, the Pro Forma Statements do not assume any material differences in accounting policies between the two companies.
The following identifies the reclassifications made to KUPIs historical financial statements in order to conform to our financial statement presentation:
|
|
KUPI 6/30/15 |
|
KUPI 6/30/15 |
|
KUPI 6/30/15 |
| |||
(In thousands) |
|
Historical |
|
Reclassifications |
|
Reclassified |
| |||
Assets |
|
|
|
|
|
|
| |||
Current assets: |
|
|
|
|
|
|
| |||
Cash and cash equivalents |
|
$ |
1,183 |
|
$ |
|
|
$ |
1,183 |
|
Accounts receivable, net |
|
188,954 |
|
10,880 |
|
199,834 |
| |||
Due from affiliates |
|
10,880 |
|
(10,880 |
) |
|
| |||
Inventories, net |
|
61,598 |
|
|
|
61,598 |
| |||
Deferred income taxes |
|
38,969 |
|
|
|
38,969 |
| |||
Other current assets |
|
1,390 |
|
|
|
1,390 |
| |||
Total current assets |
|
302,974 |
|
|
|
302,974 |
| |||
Property and equipment, net |
|
94,113 |
|
|
|
94,113 |
| |||
Intangible assets, net |
|
5,892 |
|
|
|
5,892 |
| |||
Goodwill |
|
177,957 |
|
|
|
177,957 |
| |||
Total assets |
|
$ |
580,936 |
|
$ |
|
|
$ |
580,936 |
|
|
|
|
|
|
|
|
| |||
Liabilities and Stockholders Equity |
|
|
|
|
|
|
| |||
Current liabilities: |
|
|
|
|
|
|
| |||
Accounts payable |
|
$ |
49,345 |
|
$ |
(33,065 |
) |
$ |
16,280 |
|
Accrued expenses |
|
|
|
4,826 |
|
4,826 |
| |||
Accrued payroll and payroll-related expenses |
|
|
|
10,116 |
|
10,116 |
| |||
Rebates payable |
|
|
|
8,995 |
|
8,995 |
| |||
Royalties payable |
|
|
|
9,128 |
|
9,128 |
| |||
Total current liabilities |
|
49,345 |
|
|
|
49,345 |
| |||
Deferred income taxes |
|
60 |
|
|
|
60 |
| |||
Liabilities for unrecognized tax benefits |
|
34,779 |
|
|
|
34,779 |
| |||
Other long-term liabilities |
|
1,524 |
|
|
|
1,524 |
| |||
Total liabilities |
|
85,708 |
|
|
|
85,708 |
| |||
|
|
|
|
|
|
|
| |||
Stockholders equity: |
|
|
|
|
|
|
| |||
Additional paid-in capital |
|
403,490 |
|
(168,822 |
) |
234,668 |
| |||
Retained earnings |
|
258,913 |
|
|
|
258,913 |
| |||
Receivable from parent |
|
(168,822 |
) |
168,822 |
|
|
| |||
Accumulated other comprehensive income |
|
1,647 |
|
|
|
1,647 |
| |||
Total stockholders equity |
|
495,228 |
|
|
|
495,228 |
| |||
Total liabilities and stockholders equity |
|
$ |
580,936 |
|
$ |
|
|
$ |
580,936 |
|
|
|
LTM (1) |
|
|
|
|
| |||
(In thousands) |
|
KUPI |
|
LTM (1) |
|
LTM (1) |
| |||
Net sales |
|
$ |
360,165 |
|
$ |
46,402 |
|
$ |
406,567 |
|
Net sales to related party |
|
20,174 |
|
(20,174 |
) |
|
| |||
Contract manufacturing revenue |
|
32,342 |
|
(32,342 |
) |
|
| |||
Total net revenues |
|
412,681 |
|
(6,114 |
) |
406,567 |
| |||
Cost of goods sold |
|
207,589 |
|
31,147 |
|
238,736 |
| |||
Cost of goods sold to related party |
|
7,788 |
|
(7,788 |
) |
|
| |||
Contract manufacturing costs |
|
18,633 |
|
(18,633 |
) |
|
| |||
Total cost of goods sold |
|
234,010 |
|
4,726 |
|
238,736 |
| |||
Gross profit |
|
178,671 |
|
(10,840 |
) |
167,831 |
| |||
Operating expenses: |
|
|
|
|
|
|
| |||
Research and development |
|
29,720 |
|
572 |
|
30,292 |
| |||
Selling, general and administrative expenses |
|
25,910 |
|
602 |
|
26,512 |
| |||
Selling, general and administrative expenses to related party |
|
5,101 |
|
(5,101 |
) |
|
| |||
Other expense, net |
|
6,809 |
|
(6,809 |
) |
|
| |||
Total operating expenses |
|
67,540 |
|
(10,736 |
) |
56,804 |
| |||
Operating income |
|
111,131 |
|
(104 |
) |
111,027 |
| |||
Other income (loss): |
|
|
|
|
|
|
| |||
Foreign currency loss |
|
|
|
(518 |
) |
(518 |
) | |||
Gain on sale of assets |
|
|
|
50 |
|
50 |
| |||
Total other income (loss) |
|
|
|
(468 |
) |
(468 |
) | |||
Income before provision for income taxes |
|
111,131 |
|
(572 |
) |
110,559 |
| |||
Provision for income taxes |
|
25,778 |
|
(572 |
) |
25,206 |
| |||
Net income |
|
$ |
85,353 |
|
$ |
|
|
$ |
85,353 |
|
(1) LTM represents the last twelve months ended June 30, 2015 to conform to the Lannett fiscal year end.